Utilized for gastroesophageal reflux disease to alleviate gastric acid production and support esophageal healing.
Mechanism of Action
Omeprazole irreversibly binds to the hydrogen-potassium ATPase pump in the gastric parietal cells. By inhibiting this 'proton pump,' it effectively shuts down the final pathway of stomach acid secretion.
Route of Administration
Oral
Onset Time
1–3 hours
Duration
24–72 hours
Contraindications
Hypersensitivity to omeprazole, Hypersensitivity to other benzimidazoles, Concurrent use of nelfinavir
Information related to Omeprazole is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.